Does palivizumab prophylaxe reduce hospitalization due to RSV in young children with hemodynamically significant congenital heart disease?

Autor:	Grotenhuis, H. B., Fijnvandraat, K., de Kruiff, C. C.
Přispěvatelé:	Amsterdam Cardiovascular Sciences, Amsterdam institute for Infection and Immunity, Paediatric Infectious Diseases / Rheumatology / Immunology, Amsterdam Public Health, General Paediatrics
Jazyk:	angličtina
Rok vydání:	2009
Zdroj:	Pediatric clinics Amsterdam, 20(4), 10-11
ISSN:	0928-7868
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=narcis______::450fa7b4b114c0a0fe8847cb85f423b3 https://pure.amc.nl/en/publications/does-palivizumab-prophylaxe-reduce-hospitalization-due-to-rsv-in-young-children-with-hemodynamically-significant-congenital-heart-disease(f5813877-02f2-4795-81b9-d17387055f32).html Zobrazit plný text záznamu